Compare IDEXX Laboratories, Inc. (IDXX) vs Vanguard Total Stock Market Index Fund ETF (VTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Vanguard Total Stock Market Index Fund ETF — how do they compare? IDEXX Laboratories, Inc. trades at $543.91 (market cap $43.58B), while Vanguard Total Stock Market Index Fund ETF trades at $369.03. The key difference: Vanguard Total Stock Market Index Fund ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | VTI | |
|---|---|---|
Market Cap | $43.58B | — |
Sector | Health | — |
52-Week High | $766.68 | $374.36 |
52-Week Low | $526.44 | $305.74 |
Enterprise Value | $44.48B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories trades at $552.46, down 2.64% today, with neutral technical signals but strong fundamental performance. The company maintains robust profitability with 24.63% net margins and has beaten earnings expectations for three consecutive quarters. Recent news highlights AI integration in medical devices and upcoming Q2 2026 results on August 4, 2026. The stock shows consistent revenue growth from $3.4B in 2022 to $4.3B in 2025.
Outlook remains positive given earnings momentum and analyst consensus, though elevated valuation ratios (P/E 41.49) pose risks. Key catalysts include Q2 earnings release and continued AI adoption in veterinary diagnostics. Primary risks involve competitive pressures and market volatility affecting premium valuations.
VTI trades at $366.25, down 0.21% on the day, with a bearish technical signal from moving averages and neutral oscillators. The ETF offers broad exposure to the entire U.S. stock market with over 3,500 holdings and a low 0.03% expense ratio. Recent news highlights its role in long-term portfolios and inclusion in new tax-advantaged accounts, emphasizing diversification benefits.
Outlook remains positive for long-term investors due to historical performance and cost efficiency, but near-term risks include market volatility and potential underperformance if large-cap tech stocks weaken. The bearish technical setup suggests caution for short-term traders, while fundamentals support holding for wealth accumulation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Vanguard Total Stock Market Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable US stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
Read more on VTI →
